Stock listing

NB3 Stock Price, News, Filings & Events — Neurocrine Biosciences, Inc.

Selected listing: NB3 · FWB · EUR · DE

NB3:FWB is the listing for Neurocrine Biosciences, Inc., a company dedicated to developing innovative therapies for neurological and endocrine disorders. With a significant market capitalization of around €17.18 billion, Neurocrine focuses on advancing treatments that enhance patient outcomes. The company is actively engaged in the American market, highlighting its commitment to addressing unmet medical needs through its research and development efforts. Recent news and filings may provide further insights into its ongoing projects and market activities.